Abstract
Autophagy is an evolutionary conserved lysosomal pathway functioned in the turnover of cellular macromolecules and organelles. It is known that autophagy can have a cytoprotective effect in tumor cells under therapeutic treatment. Autophagy inhibitors thus may be used as auxiliary drugs to augment the anti-tumor activity of cancer therapies. On the other hand, autophagy is a cytotoxic event that can kill tumor cells. Autophagy inducers that increase the level of autophagy thus may be developed as a new class of anti-cancer therapy. This chapter will describe the known pathway of autophagy and its relationship to cancer. The focus of this chapter is to give a summary of the known small-molecule regulators of autophagy, including inhibitors and inducers, discovered as potential therapies for cancer treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akin, D., Wang, S. K., Habibzadegah-Tari, P., Law, B., Ostrov, D., Li, M., et al. (2014). A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors. Autophagy, 10(11), 2021–2035.
Albert, J. M., Kim, K. W., Cao, C., & Lu, B. (2006). Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer. Molecular Cancer Therapeutics, 5(5), 1183–1189.
Arnold, A. A., Aboukameel, A., Chen, J., Yang, D., Wang, S., Al-Katib, A., et al. (2008). Preclinical studies of Apogossypolone: A new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model. Molecular Cancer, 7, 20.
Azad, M. B., Chen, Y., Henson, E. S., Cizeau, J., McMillan-Ward, E., Israels, S. J., et al. (2008). Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3. Autophagy, 4(2), 195–204.
Baek, K. H., Park, J., & Shin, I. (2012). Autophagy-regulating small molecules and their therapeutic applications. Chemical Society Reviews, 41(8), 3245–3263.
Balic, A., Sorensen, M. D., Trabulo, S. M., Sainz, B., Jr., Cioffi, M., Vieira, C. R., et al. (2014). Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling. Molecular Cancer Therapeutics, 13(7), 1758–1771.
Bases, R. E., & Mendez, F. (1997). Topoisomerase inhibition by lucanthone, an adjuvant in radiation therapy. International Journal of Radiation Oncology, Biology, and Physics, 37(5), 1133–1137.
Blommaart, E. F., Krause, U., Schellens, J. P., Vreeling-Sindelarova, H., & Meijer, A. J. (1997). The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. European Journal of Biochemistry, 243(1–2), 240–246.
Bonapace, L., Bornhauser, B. C., Schmitz, M., Cario, G., Ziegler, U., Niggli, F. K., et al. (2010). Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance. Journal of Clinical Investigation, 120(4), 1310–1323.
Cao, C., Subhawong, T., Albert, J. M., Kim, K. W., Geng, L., Sekhar, K. R., et al. (2006). Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. Cancer Research, 66(20), 10040–10047.
Carew, J. S., Espitia, C. M., Esquivel, J. A., 2nd, Mahalingam, D., Kelly, K. R., Reddy, G., et al. (2011). Lucanthone is a novel inhibitor of autophagy that induces cathepsin D-mediated apoptosis. Journal of Biological Chemistry, 286(8), 6602–6613.
Cerny, J., Feng, Y., Yu, A., Miyake, K., Borgonovo, B., Klumperman, J., et al. (2004). The small chemical vacuolin-1 inhibits Ca(2+)-dependent lysosomal exocytosis but not cell resealing. EMBO Reports, 5(9), 883–888.
Chen, Y. J., Chi, C. W., Su, W. C., & Huang, H. L. (2014). Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carcinoma. Oncotarget, 5(13), 4845–4854.
Chen, J., Mei, Q., Xu, Y. C., Du, J., Wei, Y., & Xu, Z. M. (2006). Effects of matrine injection on T-lymphocyte subsets of patients with malignant tumor after gamma knife radiosurgery. Zhong Xi Yi Jie He Xue Bao, 4(1), 78–79.
Chen, S., Zhu, X., Qiao, H., Ye, M., Lai, X., Yu, S., et al. (2015). Protective autophagy promotes the resistance of HER2-positive breast cancer cells to lapatinib. Tumour Biology. DIALOG. Retrieved September 14, 2015, from http://link.springer.com/article/10.1007%2Fs13277-015-3800-9
Clarke, P. G. (1990). Developmental cell death: Morphological diversity and multiple mechanisms. Anatomy and Embryology, 181(3), 195–213.
Deng, L., Lei, Y., Liu, R., Li, J., Yuan, K., Li, Y., et al. (2013). Pyrvinium targets autophagy addiction to promote cancer cell death. Cell Death & Disease, 4, e614.
Donadelli, M., Dando, I., Zaniboni, T., Costanzo, C., Dalla Pozza, E., Scupoli, M. T., et al. (2011). Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. Cell Death & Disease, 2, e152.
Fleming, A., Noda, T., Yoshimori, T., & Rubinsztein, D. C. (2011). Chemical modulators of autophagy as biological probes and potential therapeutics. Nature Chemical Biology, 7(1), 9–17.
Frisch, S. M., & Screaton, R. A. (2001). Anoikis mechanisms. Current Opinion in Cell Biology, 13(5), 555–562.
Fu, J., Shao, C. J., Chen, F. R., Ng, H. K., & Chen, Z. P. (2010). Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines. Neuro-Oncology, 12(4), 328–340.
Fukuda, T., Oda, K., Wada-Hiraike, O., Sone, K., Inaba, K., Ikeda, Y., et al. (2015). The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition. Gynecologic Oncology, 137(3), 538–545.
Fulda, S., & Kogel, D. (2015). Cell death by autophagy: Emerging molecular mechanisms and implications for cancer therapy. Oncogene, 34(40), 5105–5113.
Fung, C., Lock, R., Gao, S., Salas, E., & Debnath, J. (2008). Induction of autophagy during extracellular matrix detachment promotes cell survival. Molecular Biology of the Cell, 19(3), 797–806.
Gewirtz, D. A. (2014). The four faces of autophagy: Implications for cancer therapy. Cancer Research, 74(3), 647–651.
Goussetis, D. J., Altman, J. K., Glaser, H., McNeer, J. L., Tallman, M. S., & Platanias, L. C. (2010). Autophagy is a critical mechanism for the induction of the antileukemic effects of arsenic trioxide. Journal of Biological Chemistry, 285(39), 29989–29997.
Green, D. R., & Levine, B. (2014). To be or not to be? How selective autophagy and cell death govern cell fate. Cell, 157(1), 65–75.
Hamer, H. M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F. J., & Brummer, R. J. (2008). Review article: The role of butyrate on colonic function. Alimentary Pharmacology and Therapeutics, 27(2), 104–119.
Harada, M., Sakisaka, S., Yoshitake, M., Kin, M., Ohishi, M., Shakado, S., et al. (1996). Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPases, inhibits the receptor-mediated endocytosis of asialoglycoproteins in isolated rat hepatocytes. Journal of Hepatology, 24(5), 594–603.
He, J. H., Liao, X. L., Wang, W., Li, D. D., Chen, W. D., Deng, R., et al. (2014). Apogossypolone, a small-molecule inhibitor of Bcl-2, induces radiosensitization of nasopharyngeal carcinoma cells by stimulating autophagy. International Journal of Oncology, 45(3), 1099–1108.
Heidari, N., Hicks, M. A., & Harada, H. (2010). GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagy. Cell Death & Disease, 1, e76.
Homewood, C. A., Warhurst, D. C., Peters, W., & Baggaley, V. C. (1972). Lysosomes, pH and the anti-malarial action of chloroquine. Nature, 235(5332), 50–52.
Hoyer-Hansen, M., Bastholm, L., Szyniarowski, P., Campanella, M., Szabadkai, G., Farkas, T., et al. (2007). Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. Molecular Cell, 25(2), 193–205.
Hoyer-Hansen, M., & Jaattela, M. (2007). Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death and Differentiation, 14(9), 1576–1582.
Jangamreddy, J. R., Panigrahi, S., & Los, M. J. (2015). Monitoring of autophagy is complicated—Salinomycin as an example. Biochimica et Biophysica Acta, 1853(3), 604–610.
Jazirehi, A. R. (2010). Regulation of apoptosis-associated genes by histone deacetylase inhibitors: Implications in cancer therapy. Anti-Cancer Drugs, 21(9), 805–813.
Jung, C. H., Jun, C. B., Ro, S. H., Kim, Y. M., Otto, N. M., Cao, J., et al. (2009). ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Molecular Biology of the Cell, 20(7), 1992–2003.
Kim, Y. C., & Guan, K. L. (2015). mTOR: A pharmacologic target for autophagy regulation. Journal of Clinical Investigation, 125(1), 25–32.
Kim, J., Kim, Y. C., Fang, C., Russell, R. C., Kim, J. H., Fan, W., et al. (2013a). Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell, 152(1–2), 290–303.
Kim, Y., Kim, Y. S., Kim, D. E., Lee, J. S., Song, J. H., Kim, H. G., et al. (2013b). BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production. Autophagy, 9(12), 2126–2139.
Kimura, T., Takabatake, Y., Takahashi, A., & Isaka, Y. (2013). Chloroquine in cancer therapy: A double-edged sword of autophagy. Cancer Research, 73(1), 3–7.
Kumar, D., Shankar, S., & Srivastava, R. K. (2014). Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway. Cancer Letters, 343(2), 179–189.
Kumar, A., Singh, U. K., & Chaudhary, A. (2015). Targeting autophagy to overcome drug resistance in cancer therapy. Future Medicinal Chemistry, 7(12), 1535–1542.
Laplante, M., & Sabatini, D. M. (2012). mTOR signaling in growth control and disease. Cell, 149(2), 274–293.
Leng, S., Hao, Y., Du, D., Xie, S., Hong, L., Gu, H., et al. (2013). Ursolic acid promotes cancer cell death by inducing Atg5-dependent autophagy. International Journal of Cancer, 133(12), 2781–2790.
Levy, J. M., & Thorburn, A. (2011). Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacology and Therapeutics, 131(1), 130–141.
Li, T. L., Su, L., Zhong, N., Hao, X. X., Zhong, D. S., Singhal, S., et al. (2013). Salinomycin induces cell death with autophagy through activation of endoplasmic reticulum stress in human cancer cells. Autophagy, 9(7), 1057–1068.
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., et al. (1999). Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature, 402(6762), 672–676.
Liu, R., Li, J., Zhang, T., Zou, L., Chen, Y., Wang, K., et al. (2014). Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking. Autophagy, 10(7), 1241–1255.
Liu, T., Song, Y., Chen, H., Pan, S., & Sun, X. (2010). Matrine inhibits proliferation and induces apoptosis of pancreatic cancer cells in vitro and in vivo. Biological and Pharmaceutical Bulletin, 33(10), 1740–1745.
Lu, Y., Dong, S., Hao, B., Li, C., Zhu, K., Guo, W., et al. (2014). Vacuolin-1 potently and reversibly inhibits autophagosome-lysosome fusion by activating RAB5A. Autophagy, 10(11), 1895–1905.
Maira, S. M., Stauffer, F., Schnell, C., & Garcia-Echeverria, C. (2009). PI3K inhibitors for cancer treatment: Where do we stand? Biochemical Society Transactions, 37(Pt 1), 265–272.
Marino, G., Niso-Santano, M., Baehrecke, E. H., & Kroemer, G. (2014). Self-consumption: The interplay of autophagy and apoptosis. Nature Reviews Molecular Cell Biology, 15(2), 81–94.
Marino, G., Salvador-Montoliu, N., Fueyo, A., Knecht, E., Mizushima, N., & Lopez-Otin, C. (2007). Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. Journal of Biological Chemistry, 282(25), 18573–18583.
Mathew, R., Karantza-Wadsworth, V., & White, E. (2007). Role of autophagy in cancer. Nature Reviews Cancer, 7(12), 961–967.
Mauvezin, C., & Neufeld, T. P. (2015). Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion. Autophagy, 11(8), 1437–1438.
Maycotte, P., & Thorburn, A. (2011). Autophagy and cancer therapy. Cancer Biology and Therapy, 11(2), 127–137.
Miller, W. H., Jr., Schipper, H. M., Lee, J. S., Singer, J., & Waxman, S. (2002). Mechanisms of action of arsenic trioxide. Cancer Research, 62(14), 3893–3903.
Nagelkerke, A., Bussink, J., Geurts-Moespot, A., Sweep, F. C., & Span, P. N. (2015). Therapeutic targeting of autophagy in cancer. Part II: Pharmacological modulation of treatment-induced autophagy. Seminars in Cancer Biology, 31, 99–105.
Nakamura, M., Kikukawa, Y., Takeya, M., Mitsuya, H., & Hata, H. (2010). Clarithromycin attenuates autophagy in myeloma cells. International Journal of Oncology, 37(4), 815–820.
Nam, H. Y., Han, M. W., Chang, H. W., Lee, Y. S., Lee, M., Lee, H. J., et al. (2013). Radioresistant cancer cells can be conditioned to enter senescence by mTOR inhibition. Cancer Research, 73(14), 4267–4277.
Niu, X., Li, S., Wei, F., Huang, J., Wu, G., Xu, L., et al. (2014). Apogossypolone induces autophagy and apoptosis in breast cancer MCF-7 cells in vitro and in vivo. Breast Cancer, 21(2), 223–230.
Nomura, T., & Katunuma, N. (2005). Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. The Journal of Medical Investigation, 52(1–2), 1–9.
Pattingre, S., & Levine, B. (2006). Bcl-2 inhibition of autophagy: A new route to cancer? Cancer Research, 66(6), 2885–2888.
Plumbridge, T. W., & Brown, J. R. (1978). Studies on the mode of interaction of 4′-epi-adriamycin and 4-demethoxy-daunomycin with DNA. Biochemical Pharmacology, 27(14), 1881–1882.
Polivka, J., Jr., & Janku, F. (2014). Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacology and Therapeutics, 142(2), 164–175.
Powis, G., Bonjouklian, R., Berggren, M. M., Gallegos, A., Abraham, R., Ashendel, C., et al. (1994). Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Research, 54(9), 2419–2423.
Qu, X., Yu, J., Bhagat, G., Furuya, N., Hibshoosh, H., Troxel, A., et al. (2003). Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. Journal of Clinical Investigation, 112(12), 1809–1820.
Racoma, I. O., Meisen, W. H., Wang, Q. E., Kaur, B., & Wani, A. A. (2013). Thymoquinone inhibits autophagy and induces cathepsin-mediated, caspase-independent cell death in glioblastoma cells. PLoS One, 8(9), e72882.
Renna, M., Schaffner, C., Brown, K., Shang, S., Tamayo, M. H., Hegyi, K., et al. (2011). Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. Journal of Clinical Investigation, 121(9), 3554–3563.
Ristic, B., Bosnjak, M., Arsikin, K., Mircic, A., Suzin-Zivkovic, V., Bogdanovic, A., et al. (2014). Idarubicin induces mTOR-dependent cytotoxic autophagy in leukemic cells. Experimental Cell Research, 326(1), 90–102.
Ronan, B., Flamand, O., Vescovi, L., Dureuil, C., Durand, L., Fassy, F., et al. (2014). A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy. Nature Chemical Biology, 10(12), 1013–1019.
Rubiolo, J. A., Lopez-Alonso, H., Martinez, P., Millan, A., Cagide, E., Vieytes, M. R., et al. (2014). Yessotoxin induces ER-stress followed by autophagic cell death in glioma cells mediated by mTOR and BNIP3. Cellular Signalling, 26(2), 419–432.
Salabei, J. K., Balakumaran, A., Frey, J. C., Boor, P. J., Treinen-Moslen, M., & Conklin, D. J. (2012). Verapamil stereoisomers induce antiproliferative effects in vascular smooth muscle cells via autophagy. Toxicology and Applied Pharmacology, 262(3), 265–272.
Seglen, P. O., & Gordon, P. B. (1982). 3-Methyladenine: Specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proceedings of the National Academy of Sciences of the United States of America, 79(6), 1889–1892.
Shao, Y., Gao, Z., Marks, P. A., & Jiang, X. (2004). Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 101(52), 18030–18035.
Shimizu, S., Kanaseki, T., Mizushima, N., Mizuta, T., Arakawa-Kobayashi, S., Thompson, C. B., et al. (2004). Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nature Cell Biology, 6(12), 1221–1228.
Shimizu, S., Konishi, A., Nishida, Y., Mizuta, T., Nishina, H., Yamamoto, A., et al. (2010). Involvement of JNK in the regulation of autophagic cell death. Oncogene, 29(14), 2070–2082.
Shimizu, S., Yoshida, T., Tsujioka, M., & Arakawa, S. (2014). Autophagic cell death and cancer. International Journal of Molecular Sciences, 15(2), 3145–3153.
Sosa, M. S., Bragado, P., Debnath, J., & Aguirre-Ghiso, J. A. (2013). Regulation of tumor cell dormancy by tissue microenvironments and autophagy. Advances in Experimental Medicine & Biology, 734, 73–89.
Takahashi, A., Kimura, F., Yamanaka, A., Takebayashi, A., Kita, N., Takahashi, K., et al. (2014). Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis. Cancer Cell International, 14, 53.
Tamai, M., Matsumoto, K., Omura, S., Koyama, I., Ozawa, Y., & Hanada, K. (1986). In vitro and in vivo inhibition of cysteine proteinases by EST, a new analog of E-64. Journal of Pharmacobio-Dynamics, 9(8), 672–677.
Tanida, I., Minematsu-Ikeguchi, N., Ueno, T., & Kominami, E. (2005). Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy, 1(2), 84–91.
Thorburn, A., Thamm, D. H., & Gustafson, D. L. (2014). Autophagy and cancer therapy. Molecular Pharmacology, 85(6), 830–838.
Thorne, C. A., Hanson, A. J., Schneider, J., Tahinci, E., Orton, D., Cselenyi, C. S., et al. (2010). Small-molecule inhibition of Wnt signaling through activation of casein kinase 1alpha. Nature Chemical Biology, 6(11), 829–836.
Umezawa, H., Aoyagi, T., Morishima, H., Matsuzaki, M., & Hamada, M. (1970). Pepstatin, a new pepsin inhibitor produced by Actinomycetes. Journal of Antibiotics, 23(5), 259–262.
Vlahos, C. J., Matter, W. F., Hui, K. Y., & Brown, R. F. (1994). A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Journal of Biological Chemistry, 269(7), 5241–5248.
Voss, V., Senft, C., Lang, V., Ronellenfitsch, M. W., Steinbach, J. P., Seifert, V., et al. (2010). The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma. Molecular Cancer Research, 8(7), 1002–1016.
Wang, Y., Kuramitsu, Y., Tokuda, K., Baron, B., Kitagawa, T., Akada, J., et al. (2014). Gemcitabine induces poly (ADP-ribose) polymerase-1 (PARP-1) degradation through autophagy in pancreatic cancer. PLoS One, 9(10), e109076.
Wang, Z., Zhang, J., Wang, Y., Xing, R., Yi, C., Zhu, H., et al. (2013). Matrine, a novel autophagy inhibitor, blocks trafficking and the proteolytic activation of lysosomal proteases. Carcinogenesis, 34(1), 128–138.
Watanabe, M., Adachi, S., Matsubara, H., Imai, T., Yui, Y., Mizushima, Y., et al. (2009). Induction of autophagy in malignant rhabdoid tumor cells by the histone deacetylase inhibitor FK228 through AIF translocation. International Journal of Cancer, 124(1), 55–67.
Wei, Y., Kadia, T., Tong, W., Zhang, M., Jia, Y., Yang, H., et al. (2010). The combination of a histone deacetylase inhibitor with the BH3-mimetic GX15-070 has synergistic antileukemia activity by activating both apoptosis and autophagy. Autophagy, 6(7), 976–978.
Wirth, M., Joachim, J., & Tooze, S. A. (2013). Autophagosome formation—The role of ULK1 and Beclin1-PI3KC3 complexes in setting the stage. Seminars in Cancer Biology, 23(5), 301–309.
Wong, V. K., Li, T., Law, B. Y., Ma, E. D., Yip, N. C., Michelangeli, F., et al. (2013). Saikosaponin-d, a novel SERCA inhibitor, induces autophagic cell death in apoptosis-defective cells. Cell Death & Disease, 4, e720.
Wu, L., & Yan, B. (2011). Discovery of small molecules that target autophagy for cancer treatment. Current Medicinal Chemistry, 18(12), 1866–1873.
Yamamoto, S., Tanaka, K., Sakimura, R., Okada, T., Nakamura, T., Li, Y., et al. (2008). Suberoylanilide hydroxamic acid (SAHA) induces apoptosis or autophagy-associated cell death in chondrosarcoma cell lines. Anticancer Research, 28(3A), 1585–1591.
You, D., Kim, Y., Jang, M. J., Lee, C., Jeong, I. G., Cho, Y. M., et al. (2015). KML001 induces apoptosis and autophagic cell death in prostate cancer cells via oxidative stress pathway. PLoS One, 10(9), e0137589.
Yu, H. C., Lin, C. S., Tai, W. T., Liu, C. Y., Shiau, C. W., & Chen, K. F. (2013). Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation. Journal of Biological Chemistry, 288(25), 18249–18259.
Yue, W., Hamai, A., Tonelli, G., Bauvy, C., Nicolas, V., Tharinger, H., et al. (2013). Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance. Autophagy, 9(5), 714–729.
Zhang, X. Q., Huang, X. F., Hu, X. B., Zhan, Y. H., An, Q. X., Yang, S. M., et al. (2010). Apogossypolone, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces autophagy of PC-3 and LNCaP prostate cancer cells in vitro. Asian Journal of Andrology, 12(5), 697–708.
Zhang, C., Richon, V., Ni, X., Talpur, R., & Duvic, M. (2005). Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: Relevance to mechanism of therapeutic action. Journal of Investigative Dermatology, 125(5), 1045–1052.
Zhou, M., & Wang, R. (2013). Small-molecule regulators of autophagy and their potential therapeutic applications. ChemMedChem, 8(5), 694–707.
Zhu, X. X., Yao, X. F., Jiang, L. P., Geng, C. Y., Zhong, L. F., Yang, G., et al. (2014). Sodium arsenite induces ROS-dependent autophagic cell death in pancreatic beta-cells. Food and Chemical Toxicology, 70, 144–150.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Li, Q., Zhou, M., Wang, R. (2016). Small-Molecule Regulators of Autophagy as Potential Anti-cancer Therapy. In: Yang, JM. (eds) Targeting Autophagy in Cancer Therapy. Current Cancer Research. Springer, Cham. https://doi.org/10.1007/978-3-319-42740-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-42740-9_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42738-6
Online ISBN: 978-3-319-42740-9
eBook Packages: MedicineMedicine (R0)